Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma
Emily R. Theisen(University of Utah), Margit M. Janát‐Amsbury(University of Utah)
Cited by 50
Related Papers
Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis
|Genes & Cancer|2019|30
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins
|bioRxiv (Cold Spring Harbor Laboratory)|2024|3
<i>N</i> ′-(1-Phenylethylidene)benzohydrazide Cytotoxicity Is Lysine-Specific Demethylase 1 Independent and Linked to Iron–Sulfur Cluster Disruption in Ewing Sarcoma
|ACS Pharmacology & Translational Science|2025|2
Abstract P087: Targeting LSD1 protein scaffolding function in FET-rearranged sarcomas with SP-2577
|Molecular Cancer Therapeutics|2021|1
N’-(1-phenylethylidene)-benzohydrazide cytotoxicity is LSD1 independent and linked to Fe-S cluster disruption in Ewing sarcoma
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0